Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

Last updated on 2022-07-15 History
Report ID 147650
Drug Identification Number 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 24 x 100mL bag
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-10-25
Estimated end date 2022-10-17
Actual end date
Shortage status Actual shortage
Updated date 2022-07-15
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-07-15 French Compare
v11 2022-07-15 English Compare
v10 2022-03-23 French Compare
v9 2022-03-23 English Compare
v8 2022-01-14 French Compare
v7 2022-01-14 English Compare
v6 2022-01-13 English Compare
v5 2021-10-26 English Compare
v4 2021-10-25 French Compare
v3 2021-10-25 English Compare
v2 2021-10-20 French Compare
v1 2021-10-20 English Compare

Showing 1 to 12 of 12